I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
Clinical trial NCT04488081 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04488081
- Sponsor
- QuantumLeap Healthcare Collaborative
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-31
- Primary completion
- 2028-07-31
- Enrollment
- 1500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.